| 31st Jul 2026 5:32 pm |
RNS |
Holding(s) in Company |
| 31st Jul 2026 7:00 am |
RNS |
Extension of Option Exercise Period |
| 28th Jul 2026 3:40 pm |
RNS |
Holding(s) in Company |
| 27th Jul 2026 7:00 am |
RNS |
Result of Retail Offer and Total Voting Rights |
| 24th Jul 2026 7:30 am |
RNS |
Correction: Merger and Financing |
| 23rd Jul 2026 4:30 pm |
RNS |
Oversubscribed UK Placing |
| 23rd Jul 2026 8:05 am |
RNS |
Merger and Financing |
| 23rd Jul 2026 8:04 am |
RNS |
Launch of Retail Offer |
| 23rd Jul 2026 8:04 am |
RNS |
Proposed UK Placing |
| 26th Jun 2026 2:13 pm |
RNS |
Scancell: Response to Press Speculation |
| 28th Apr 2026 7:00 am |
RNS |
FDA Fast Track Designation for iSCIB1+ |
| 2nd Apr 2026 7:00 am |
RNS |
Scancell announces CFO transition |
| 29th Jan 2026 7:00 am |
RNS |
Half-year Financial Report |
| 26th Jan 2026 7:00 am |
RNS |
FDA clearance of IND application for iSCIB1+ |
| 22nd Jan 2026 7:00 am |
RNS |
Notice of Results |
| 9th Dec 2025 7:00 am |
RNS |
Continued improvement in PFS with iSCIB1+ |
| 7th Nov 2025 7:00 am |
RNS |
Research Update |
| 30th Oct 2025 3:30 pm |
RNS |
Result of AGM |
| 3rd Oct 2025 7:00 am |
RNS |
Notice of AGM |
| 16th Sep 2025 7:00 am |
RNS |
Director Dealing |
| 11th Sep 2025 7:00 am |
RNS |
Final Results |
| 4th Sep 2025 7:00 am |
RNS |
Notice of Results |
| 8th Aug 2025 12:31 pm |
RNS |
Director Dealing |
| 4th Aug 2025 10:23 am |
RNS |
Director/PDMR Shareholding |
| 22nd Jul 2025 7:00 am |
RNS |
Strong Phase 2 data on iSCIB1+ in Melanoma |
| 16th Jul 2025 7:00 am |
RNS |
Share Option Exercise |
| 25th Jun 2025 7:00 am |
RNS |
Scancell initiates new arm in SCOPE Phase 2 study |
| 21st May 2025 7:00 am |
RNS |
Director Dealing |
| 14th Apr 2025 7:00 am |
RNS |
Partnership with NHS Cancer Vaccine Launch Pad |
| 1st Apr 2025 7:00 am |
RNS |
Scancell to present at 2025 AACR Annual Meeting |
| 20th Feb 2025 7:00 am |
RNS |
Issue of share options |
| 17th Feb 2025 7:00 am |
RNS |
Scancell presenting at AACR IO conference |
| 30th Jan 2025 7:00 am |
RNS |
Interim Results |
| 23rd Jan 2025 7:00 am |
RNS |
Notice of Interim Results |
| 9th Jan 2025 7:00 am |
RNS |
Modi-1 Vaccine Achieves Early Clinical Validation |
| 9th Dec 2024 11:41 am |
RNS |
Result of Retail Offer and Total Voting Rights |
| 5th Dec 2024 12:39 pm |
RNS |
Result of Placing and Subscription |
| 4th Dec 2024 6:03 pm |
RNS |
Retail Offer for up to £1 million |
| 4th Dec 2024 5:59 pm |
RNS |
Proposed fundraise in excess of £8.5 million |
| 4th Dec 2024 7:00 am |
RNS |
Second Commercial License Agreement with Genmab |
